European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-28

OsteoMotion: Analyzing the mechanisms and role of osteogenic cell movement in bone development and disease

Cel

Bone development and homeostasis must incontestably rely on a correct spatial positioning of osteoblasts to generate bone at appropriate sites. A failure of osteoblasts to reach the sites in need of bone formation may contribute to impaired fracture repair and osteoporosis. Conversely, uncontrolled osteogenic cell movement may play a role in diseases involving aberrant placement of bone. Mechanisms of osteoblastic migration and adhesion may even be mimicked by bone-metastasizing tumor cells. Yet, the trafficking of osteogenic cells has been a largely neglected aspect in bone biology. My recent studies abroad for the first time shed light on this process in vivo. Newly generated transgenic mouse models for osteoblast lineage tracing revealed that specifically osteoprogenitors, and not mature osteoblasts, moved to initiate novel sites of bone formation. Intriguingly, osteoprogenitors entered developing and healing bones along with their neovascularization, some being wrapped as pericytes around the blood vessels, suggesting an unprecedented vessel-guided cell movement mechanism.
Implementing these concepts and models, I here propose two angles to elucidate the mechanisms mediating osteoprogenitor motility. In a first approach, we will assess the involvement, in vitro and in vivo, of known candidate molecular targets of (i) cell-matrix interactions pivotal in cell migration, (ii) cell-cell adhesion, and (iii) the association between pericytes and endothelial cells. Secondly, a high-risk high-gain reverse approach using innovative technologies aims to identify the specific genetic profiles of motile osteoprogenitors and bone-anchored mature osteoblasts.
Overall this project will bring novel mechanistic insight in osteogenic cell movement in bone biology and pathology, and add to our broader understanding of cell migration and progenitor properties. The potential to evoke new therapies to widespread skeletal pathologies underscores the study’s importance and high impact.

Zaproszenie do składania wniosków

ERC-2011-StG_20101109
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

ERC-SG - ERC Starting Grant

Instytucja przyjmująca

KATHOLIEKE UNIVERSITEIT LEUVEN
Wkład UE
€ 1 499 200,00
Adres
OUDE MARKT 13
3000 Leuven
Belgia

Zobacz na mapie

Region
Vlaams Gewest Prov. Vlaams-Brabant Arr. Leuven
Rodzaj działalności
Higher or Secondary Education Establishments
Kierownik naukowy
Christa Renée Julie Emilia C. Maes (Prof.)
Kontakt administracyjny
Stijn Delauré (Dr.)
Linki
Koszt całkowity
Brak danych

Beneficjenci (1)